Figure S1, Figure S2, Table S1 from Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors

Authors:
  • MGMaria Grigoriou
    Maria Grigoriou
  • ABAggelos Banos
    Aggelos Banos
  • AHAikaterini Hatzioannou
    Aikaterini Hatzioannou
  • AKAndreas Kloetgen
    Andreas Kloetgen
  • PKPanagiotis Kouzis
    Panagiotis Kouzis
  • DADespoina Aggouraki
    Despoina Aggouraki
  • RZRoubini Zakopoulou
    Roubini Zakopoulou
  • GBGiorgos Bamias
    Giorgos Bamias
  • EKEva Kassi
    Eva Kassi
  • DMDimitrios Mavroudis
    Dimitrios Mavroudis
  • DBDimitrios T. Boumpas
    Dimitrios T. Boumpas

Abstract
No abstract available